Cargando…
ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
Background: Hepatitis B virus (HBV) is a causative agent of hepatocellular carcinoma (HCC). Until now, the mechanism behind the progress of hepatitis B fibrosis to HCC remains largely unknown. This study aims to examine the candidate biomarkers and pathways involved in HBV-associated HCC. Methods: G...
Autores principales: | Tan, Siyou, Chen, Wenyan, Kong, Gaoyin, Wei, Lai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580902/ https://www.ncbi.nlm.nih.gov/pubmed/36304312 http://dx.doi.org/10.3389/fbinf.2022.871027 |
Ejemplares similares
-
Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
por: Zhang, Kainan, et al.
Publicado: (2022) -
CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis
por: Gu, Xuefeng, et al.
Publicado: (2019) -
Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma
por: Wang, Qingqing, et al.
Publicado: (2021) -
Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
por: Fu, Yang, et al.
Publicado: (2019) -
Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma
por: Liu, Xianhui, et al.
Publicado: (2020)